Novel diagnostic method for malignant melanoma using fluorescence in situ hybridization (FISH) method

Novel diagnostic method for malignant melanoma using fluorescence in situ hybridization (FISH) method - Diagnosis of Malignant Melanoma by FISH

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026396

Enrollment

Registered

2017-03-04

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant melanoma

Interventions

A skin biopsy is performed on a skin lesion suspected of malignant melanoma and a specimen for carrying out the FISH method is prepared from the harvested tissue.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with skin lesions suspected of malignant melanoma 2) over 20 years old 3) patients who obtain document consent by free will

Exclusion criteria

Exclusion criteria: 1) Patients who can not perform skin biopsy 2) Patients who are judged inappropriate for this trial by their attending physician

Design outcomes

Primary

Measure	Time frame
Presence or absence of signal detection by fluorescence in situ hybridization (FISH) method for three regions (6p25, 6q23, 11q13) in lesions suspected of malignant melanoma	—

Countries

Japan

Contacts

Public ContactJun Aoi

Kumamoto University Department of Dermatology and Plastic Surgery, Faculty of Life Sciences

junjunaoi@gmail.com096-373-5233

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026